Persons with dispensed medicines; background; 2006-2020
| Sex | Age | Background and generation | Medicine group (ATC) | Periods | Persons with medicines, relative (%) |
|---|---|---|---|---|---|
| Total male and female | Total age | Other non-western background | A05 Bile and liver therapy | 2020 | 0.06 |
| Total male and female | Total age | Other non-western background | A05A Bile therapy | 2020 | 0.06 |
| Total male and female | Total age | Other non-western background | A05B Liver therapy, lipotropics | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | A05C Bile therapy drugs and lipotropics | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | A07X Other antidiarrheals | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | A10X Other drugs used in diabetes | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | A11C Vit A and D, incl.combin.of the two | 2020 | 7.70 |
| Total male and female | Total age | Other non-western background | A11H Other plain vitamin preparations | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | A11J Other vitamin products + combinat. | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | A12C Other mineral supplements | 2020 | 0.02 |
| Total male and female | Total age | Other non-western background | A14B Other anabolic agents | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | A16 Other aliment.tract/metabol.products | 2020 | 0.01 |
| Total male and female | Total age | Other non-western background | B02B Vitamin k and other hemostatics | 2020 | 0.03 |
| Total male and female | Total age | Other non-western background | B03X Other antianemic preparations | 2020 | 0.04 |
| Total male and female | Total age | Other non-western background | B06 Other hematological agents | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | B06A Other hematological agents | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | C01 Cardiac therapy | 2020 | 0.82 |
| Total male and female | Total age | Other non-western background | C01E Other cardiac preparations | 2020 | 0.03 |
| Total male and female | Total age | Other non-western background | C02K Other antihypertensives | 2020 | 0.01 |
| Total male and female | Total age | Other non-western background | C03X Other diuretics | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | C05B Antivaricose therapy | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | C07C Beta block.agents / other diuretics | 2020 | 0.02 |
| Total male and female | Total age | Other non-western background | C07D Beta block./thiazides/other diuret. | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | C07F Beta block./other antihypertensives | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | C09X Other renin angiotensin syst.agents | 2020 | 0.01 |
| Total male and female | Total age | Other non-western background | D04 Antipruritics,incl antesthetics .... | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | D06B Chemotherapeutics for topical use | 2020 | 0.54 |
| Total male and female | Total age | Other non-western background | D06C Antibiotics/chemotherapeutics, comb | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | D07X Corticosteroids, other combinations | 2020 | 0.17 |
| Total male and female | Total age | Other non-western background | D11 Other dermatological preparations | 2020 | 0.73 |
| Total male and female | Total age | Other non-western background | D11A Other dermatological preparations | 2020 | 0.73 |
| Total male and female | Total age | Other non-western background | G02 Other gynecologicals | 2020 | 0.11 |
| Total male and female | Total age | Other non-western background | G02C Other gynecologicals | 2020 | 0.06 |
| Total male and female | Total age | Other non-western background | H03 Thyroid therapy | 2020 | 1.89 |
| Total male and female | Total age | Other non-western background | H03C Iodine therapy | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | J01D Other beta-lactam antibacterials | 2020 | 0.09 |
| Total male and female | Total age | Other non-western background | J01X Other antibacterials | 2020 | 2.46 |
| Total male and female | Total age | Other non-western background | J07X Other vaccines | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | L01X Other antineoplastic agents | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | L02 Endocrine therapy | 2020 | 0.22 |
| Total male and female | Total age | Other non-western background | N01 Anesthetics | 2020 | 1.00 |
| Total male and female | Total age | Other non-western background | N01A Anesthetics, general | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | N01B Anesthetics, local | 2020 | 1.00 |
| Total male and female | Total age | Other non-western background | N02B Other analgesics and antipyretics | 2020 | 0.03 |
| Total male and female | Total age | Other non-western background | N07 Other nervous system drugs | 2020 | 0.48 |
| Total male and female | Total age | Other non-western background | N07X Other nervous system drugs | 2020 | 0.01 |
| Total male and female | Total age | Other non-western background | P01A Amoebiasis / other protozoal dis. | 2020 | 0.83 |
| Total male and female | Total age | Other non-western background | P02 Anthelmintics | 2020 | 0.02 |
| Total male and female | Total age | Other non-western background | R05X Other cold combination preparations | 2020 | 0.00 |
| Total male and female | Total age | Other non-western background | R07 Other respiratory system products | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | A05 Bile and liver therapy | 2020 | 0.01 |
| Total male and female | 0 to 14 years | Other non-western background | A05A Bile therapy | 2020 | 0.01 |
| Total male and female | 0 to 14 years | Other non-western background | A05B Liver therapy, lipotropics | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | A05C Bile therapy drugs and lipotropics | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | A07X Other antidiarrheals | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | A10X Other drugs used in diabetes | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | A11C Vit A and D, incl.combin.of the two | 2020 | 0.86 |
| Total male and female | 0 to 14 years | Other non-western background | A11H Other plain vitamin preparations | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | A11J Other vitamin products + combinat. | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | A12C Other mineral supplements | 2020 | 0.02 |
| Total male and female | 0 to 14 years | Other non-western background | A14B Other anabolic agents | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | A16 Other aliment.tract/metabol.products | 2020 | 0.02 |
| Total male and female | 0 to 14 years | Other non-western background | B02B Vitamin k and other hemostatics | 2020 | 0.01 |
| Total male and female | 0 to 14 years | Other non-western background | B03X Other antianemic preparations | 2020 | 0.01 |
| Total male and female | 0 to 14 years | Other non-western background | B06 Other hematological agents | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | B06A Other hematological agents | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | C01 Cardiac therapy | 2020 | 0.34 |
| Total male and female | 0 to 14 years | Other non-western background | C01E Other cardiac preparations | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | C02K Other antihypertensives | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | C03X Other diuretics | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | C05B Antivaricose therapy | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | C07C Beta block.agents / other diuretics | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | C07D Beta block./thiazides/other diuret. | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | C07F Beta block./other antihypertensives | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | C09X Other renin angiotensin syst.agents | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | D04 Antipruritics,incl antesthetics .... | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | D06B Chemotherapeutics for topical use | 2020 | 0.13 |
| Total male and female | 0 to 14 years | Other non-western background | D06C Antibiotics/chemotherapeutics, comb | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | D07X Corticosteroids, other combinations | 2020 | 0.05 |
| Total male and female | 0 to 14 years | Other non-western background | D11 Other dermatological preparations | 2020 | 0.47 |
| Total male and female | 0 to 14 years | Other non-western background | D11A Other dermatological preparations | 2020 | 0.47 |
| Total male and female | 0 to 14 years | Other non-western background | G02 Other gynecologicals | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | G02C Other gynecologicals | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | H03 Thyroid therapy | 2020 | 0.10 |
| Total male and female | 0 to 14 years | Other non-western background | H03C Iodine therapy | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | J01D Other beta-lactam antibacterials | 2020 | 0.01 |
| Total male and female | 0 to 14 years | Other non-western background | J01X Other antibacterials | 2020 | 0.71 |
| Total male and female | 0 to 14 years | Other non-western background | J07X Other vaccines | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | L01X Other antineoplastic agents | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | L02 Endocrine therapy | 2020 | 0.07 |
| Total male and female | 0 to 14 years | Other non-western background | N01 Anesthetics | 2020 | 0.86 |
| Total male and female | 0 to 14 years | Other non-western background | N01A Anesthetics, general | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | N01B Anesthetics, local | 2020 | 0.86 |
| Total male and female | 0 to 14 years | Other non-western background | N02B Other analgesics and antipyretics | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | N07 Other nervous system drugs | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | N07X Other nervous system drugs | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | P01A Amoebiasis / other protozoal dis. | 2020 | 0.13 |
| Total male and female | 0 to 14 years | Other non-western background | P02 Anthelmintics | 2020 | 0.01 |
| Total male and female | 0 to 14 years | Other non-western background | R05X Other cold combination preparations | 2020 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | R07 Other respiratory system products | 2020 | 0.00 |
| Source: CBS. | |||||
Dataset is not available.
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
CBS is switching to a new population classification by origin. Greater emphasis will be placed on where a person was born and less on where their parents were born. The term ‘migration background’ will no longer be used in this regard. The main categories western/non-western will be replaced by categories based on continents and a few countries that share a specific migration history with the Netherlands. This classification will gradually been introduced in tables and publications with population by origin.
Data are broken down by medicine group, background, generation, age and sex.
Data available from 2006 to 2020.
Status of the figures:
All figures are definite.
Changes as of 14 December, 2022:
Figures for 2020 have been made final without change and the table has been stopped due to the introduction of the new classification of population by origin.
When will new figures be published?
Not applicable, the table has been stopped. This table will be replaced by the new table 'Persons with dispensed medicines; origin', see chapter 3.
Description topics
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.